Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MIDOSTAURIN, with a corresponding US DMF Number 35289.
Remarkably, this DMF maintains an Active status since its submission on November 26, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 02, 2021, and payment made on October 09, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II